| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net sales | 425,864 | 503,612 | ||
| Cost of sales | 171,401 | 200,954 | ||
| Gross profit | 254,463 | 302,658 | ||
| Selling and marketing | 358,535 | 345,505 | ||
| Research and development | 227,993 | 228,606 | ||
| General and administrative | 1,122,684 | 1,564,967 | ||
| Depreciation and amortization of intangible assets | 16,268 | 22,184 | ||
| Total operating expenses | 1,725,480 | 2,161,262 | ||
| Loss from operations | -1,471,017 | -1,858,604 | ||
| Other income | 7,299 | 4,357 | ||
| Interest expense | 5,059 | 2,561 | ||
| Change in fair value of earnout liabilities | -86,104 | 29,630 | ||
| Inventory write-down | 47,082 | - | ||
| Amortization of debt discount | 0 | 0 | ||
| Loss on forward purchase agreement | 0 | 0 | ||
| Loss on lease termination | 0 | - | ||
| Total other income (expense) | 41,262 | -27,834 | ||
| Loss from continuing operations before income taxes | -1,429,755 | -1,886,438 | ||
| Income tax benefit | 0 | 0 | ||
| Loss from continuing operations | -1,429,755 | -1,886,438 | ||
| Loss from discontinued operations | 0 | 0 | ||
| Gain on sale of discontinued operations | 0 | 0 | ||
| Net loss | -1,429,755 | -1,886,438 | ||
| Basic net income (loss) per share | -0.83 | -1.56 | ||
| Diluted net income (loss) per share | -0.83 | -1.56 | ||
| Weighted average shares outstanding, basic | 1,723,434 | 1,209,809 | ||
| Weighted average shares outstanding, diluted | 1,723,434 | 1,209,809 | ||
Longevity Health Holdings, Inc. (XAGEW)
Longevity Health Holdings, Inc. (XAGEW)